GS-3242

GS-3242 · Gilead Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GS-3242, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of GS-3242 in Participants With HIV-1; Substudy-05 [Phase 1]